Notwithstanding any other law, in a circumstance involving the provision of prescription drugs or intravenous infusions for which the patient is receiving benefits under the health insurance policy, the enrollee is:

(1) entitled to an immediate appeal to an independent review organization as provided by Subchapter I; and

(2) not required to comply with procedures for an internal review of the utilization review agent’s adverse determination.

Added by Acts 2015, 84th Leg., ch. 1037 (H.B. 1621), § 7, eff. Sept. 1, 2015.